News of the WeekEUROPEAN PATENTS

Stem Cell Claims Face Legal Hurdles

Science  24 Sep 2004:
Vol. 305, Issue 5692, pp. 1887
DOI: 10.1126/science.305.5692.1887a

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

The European Patent Office has rejected two applications involving human embryonic stem cells and limited a third, signaling a wide gap between policies at EPO and those of the U.S. Patent and Trademark Office, which has granted dozens of patents involving cells derived from human embryos.

Related Content